Pharma News - Chemdiv

Lilly slashes insulin price 70%, patient cost cap now $35

Indianapolis-based drugmaker Eli Lilly and Company has announced price reductions of 70% for its most commonly prescribed insulins, as well as expansion of its Insulin Value Program, capping patien...

US spent nearly $32B in public funds on mRNA vaccine development, study finds

The US government contributed at least $31.9 billion in public funding to the development of mRNA-based Covid-19 vaccines, according to a new BMJ study.

Jazz Pharmaceuticals Loses REMS Patent Appeal

A federal appeals court has rejected Jazz Pharmaceuticals’ attempt to overturn a lower court ruling invalidating a patent claim covering the company’s Risk Evaluation and Mitigation Strategies...

Confo hands baton to Lilly for non-opioid pain med development in $40M upfront deal

Confo biotech hopes that CFTX-1554 can address pain without causing side effects common with opioids and other pain meds, such as addiction and sedation. ...

ForCast Orthopedics Gets QIDP Nod for Investigational Antibiotic

The FDA has granted a Qualified Infectious Disease Product (QIDP) designation to ForCast Orthopedics’ FC001 antibiotic candidate to treat patients with periprosthetic joint infection, a rare com...

Gene Therapy Consortium to Launch Rare Diseases Pilot

The FDA will soon announce a new pilot program to help developers of gene therapies for rare diseases get their treatments approved faster, said Peter Marks, director of the FDA’s Center for Biologi...

FDA’s approval of Friedreich’s ataxia drug is a game changer for treatment of rare diseases

Reata Pharmaceuticals is aiming to make the drug omaveloxolone available by the second quarter of 2023.

FDA Offers Advice on Macular Degeneration Drug Trials

The FDA outlined drug trial options for developers of neovascular age-related macular degeneration drugs in a newly published draf

t guidance.

FDA Accepts IND and Grants Priority Review for SpringWorks Desmoid Tumors Therapeutic

The U.S. Food and Drug Administration has accepted for Priority Review SpringWorks Therapeutics’ New Drug Application for nirogacestat, an investigational gamma secretase inhibitor, for the treat...

Dr. Reddy's bolsters US generics business with $105M deal to buy Mayne Pharma assets

More generic products will soon join the fold at Dr. Reddy’s Laboratories as the drugmaker has agreed to spend up to $105 million to purchase Mayne Pharma’s U.S. copycats portfolio. ...

FDA Approves Sanofi and Sobi’s Altuviiio for Hemophilia A

The FDA has approved Sanofi and Sobi’s Altuviiio for adults and children with Hemophilia A, for use in prophylaxis, perioperative management during surgery and on-demand treatment to control blee...

First-of-its-kind study examines the impact of cannabis use on surgical patients' post-procedure healthcare needs

As legislation in multiple states eases former restrictions around medical and recreational cannabis in the United States, an increasing proportion of the population reports use of the drug. Betwe...

Pharma News, 2023